Literature DB >> 30811921

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.

Omer Diker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30811921     DOI： 10.1056/NEJMc1900123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer.

Authors:  Mengting Zhou; Jun Fan; Zhenyu Li; Pindong Li; Yajie Sun; Yuhui Yang; Xiaoshu Zhou; Jing Wang; Ye Wang; Huiwei Qi; Weijing Cai; Xiaofang Dai; Fred R Hirsch
Journal:  Respir Res       Date:  2019-11-07

2.  Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).

Authors:  Yue Li; Hailin Liu; Yujie Zhao; Dongsheng Yue; Chen Chen; Chenguang Li; Zhenfa Zhang; Changli Wang
Journal:  Thorac Cancer       Date:  2021-08-22       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.